Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 265

1.

Nicotine modulates growth factors and microRNA to promote inflammatory and fibrotic processes.

Ebrahimpour AT, Shrestha S, Bonnen MD, Eissa NTT, Raghu G, Ghebre YT.

J Pharmacol Exp Ther. 2018 Nov 16. pii: jpet.118.252650. doi: 10.1124/jpet.118.252650. [Epub ahead of print]

PMID:
30446578
2.

Response to Letter to Editor regarding "Sarcoidosis and IPF in the same patient-a coincidence, an association or a phenotype?"

Collins BF, Raghu G.

Respir Med. 2018 Oct 27. pii: S0954-6111(18)30345-7. doi: 10.1016/j.rmed.2018.10.029. [Epub ahead of print] No abstract available.

PMID:
30389206
3.

SAR156597 in idiopathic pulmonary fibrosis: a phase 2, placebo-controlled study (DRI11772).

Raghu G, Richeldi L, Crestani B, Wung P, Bejuit R, Esperet C, Antoni C, Soubrane C.

Eur Respir J. 2018 Oct 18. pii: 1801130. doi: 10.1183/13993003.01130-2018. [Epub ahead of print]

PMID:
30337444
4.

Cardiac sarcoidosis: Diagnosis confirmation by bronchoalveolar lavage and lung biopsy.

Petek BJ, Rosenthal DG, Patton KK, Behnia S, Keller JM, Collins BF, Cheng RK, Ho LA, Bravo PE, Mikacenic C, Raghu G.

Respir Med. 2018 Nov;144S:S13-S19. doi: 10.1016/j.rmed.2018.09.008. Epub 2018 Sep 16.

PMID:
30249376
5.

Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis.

Kolb M, Raghu G, Wells AU, Behr J, Richeldi L, Schinzel B, Quaresma M, Stowasser S, Martinez FJ; INSTAGE Investigators.

N Engl J Med. 2018 Nov 1;379(18):1722-1731. doi: 10.1056/NEJMoa1811737. Epub 2018 Sep 15.

PMID:
30220235
6.

Diagnosing idiopathic pulmonary fibrosis in 2018: bridging recommendations made by experts serving different societies.

Richeldi L, Wilson KC, Raghu G.

Eur Respir J. 2018 Sep 6;52(3). pii: 1801485. doi: 10.1183/13993003.01485-2018. Print 2018 Sep. No abstract available.

PMID:
30190265
7.

Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials.

Costabel U, Behr J, Crestani B, Stansen W, Schlenker-Herceg R, Stowasser S, Raghu G.

Respir Res. 2018 Sep 3;19(1):167. doi: 10.1186/s12931-018-0866-0.

8.

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, Flaherty KR, Wells A, Martinez FJ, Azuma A, Bice TJ, Bouros D, Brown KK, Collard HR, Duggal A, Galvin L, Inoue Y, Jenkins RG, Johkoh T, Kazerooni EA, Kitaichi M, Knight SL, Mansour G, Nicholson AG, Pipavath SNJ, Buendía-Roldán I, Selman M, Travis WD, Walsh S, Wilson KC; American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society.

Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.

PMID:
30168753
9.

Understanding the evolving phenotype of vascular complications in telomere biology disorders.

Higgs C, Crow YJ, Adams DM, Chang E, Hayes D Jr, Herbig U, Huang JN, Himes R, Jajoo K, Johnson FB, Reynolds SD, Yonekawa Y, Armanios M, Boulad F, DiNardo CD, Dufour C, Goldman FD, Khan S, Kratz C, Myers KC, Raghu G, Alter BP, Aubert G, Bhala S, Cowen EW, Dror Y, El-Youssef M, Friedman B, Giri N, Helms Guba L, Khincha PP, Lin TF, Longhurst H, McReynolds LJ, Nelson A, Olson T, Pariser A, Perona R, Sasa G, Schratz K, Simonetto DA, Townsley D, Walsh M, Stevens K, Agarwal S, Bertuch AA, Savage SA; Clinical Care Consortium for Telomere-associated Ailments (CCCTAA).

Angiogenesis. 2018 Aug 25. doi: 10.1007/s10456-018-9640-7. [Epub ahead of print]

PMID:
30168024
10.

Sarcoidosis and IPF in the same patient-a coincidence, an association or a phenotype?

Collins BF, McClelland RL, Ho LA, Mikacenic CR, Hayes J, Spada C, Raghu G.

Respir Med. 2018 Nov;144S:S20-S27. doi: 10.1016/j.rmed.2018.08.008. Epub 2018 Aug 23.

PMID:
30166087
11.

Quantitative high-resolution computed tomography fibrosis score: performance characteristics in idiopathic pulmonary fibrosis.

Humphries SM, Swigris JJ, Brown KK, Strand M, Gong Q, Sundy JS, Raghu G, Schwarz MI, Flaherty KR, Sood R, O'Riordan TG, Lynch DA.

Eur Respir J. 2018 Sep 17;52(3). pii: 1801384. doi: 10.1183/13993003.01384-2018. Print 2018 Sep.

PMID:
30139770
12.

Accuracy of Digital Tomosynthesis of the Chest in Detection of Interstitial Lung Disease Comparison With Digital Chest Radiography.

Kruamak T, Edwards R, Cheng S, Hippe DS, Raghu G, Pipavath SNJ.

J Comput Assist Tomogr. 2018 Aug 16. doi: 10.1097/RCT.0000000000000780. [Epub ahead of print]

PMID:
30119061
13.

Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial.

Raghu G, Pellegrini CA, Yow E, Flaherty KR, Meyer K, Noth I, Scholand MB, Cello J, Ho LA, Pipavath S, Lee JS, Lin J, Maloney J, Martinez FJ, Morrow E, Patti MG, Rogers S, Wolters PJ, Yates R, Anstrom KJ, Collard HR.

Lancet Respir Med. 2018 Sep;6(9):707-714. doi: 10.1016/S2213-2600(18)30301-1. Epub 2018 Aug 9.

PMID:
30100404
14.

Invasive Hemodynamics and Rejection Rates in Patients With Cardiac Sarcoidosis After Heart Transplantation.

Rosenthal DG, Anderson ME, Petek BJ, Arnett DM, Bravo PE, Raghu G, Goldberger ZD, Patton KK, Cheng RK.

Can J Cardiol. 2018 Aug;34(8):978-982. doi: 10.1016/j.cjca.2018.03.021. Epub 2018 Apr 6.

PMID:
30049365
15.

Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis: The Future of Quantitative Analysis.

Wu X, Kim GH, Salisbury ML, Barber D, Bartholmai BJ, Brown KK, Conoscenti CS, De Backer J, Flaherty KR, Gruden JF, Hoffman EA, Humphries SM, Jacob J, Maher TM, Raghu G, Richeldi L, Ross BD, Schlenker-Herceg R, Sverzellati N, Wells AU, Martinez FJ, Lynch DA, Goldin J, Walsh SLF.

Am J Respir Crit Care Med. 2018 Jul 9. doi: 10.1164/rccm.201803-0444PP. [Epub ahead of print]

16.

Collagen biomarkers and subclinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis.

Madahar P, Duprez DA, Podolanczuk AJ, Bernstein EJ, Kawut SM, Raghu G, Barr RG, Gross MD, Jacobs DR Jr, Lederer DJ.

Respir Med. 2018 Jul;140:108-114. doi: 10.1016/j.rmed.2018.06.001. Epub 2018 Jun 6.

PMID:
29957270
17.

Gastro-oesophageal reflux and idiopathic pulmonary fibrosis: the heart burn in patients with IPF can no longer be silent.

Kreuter M, Raghu G.

Eur Respir J. 2018 Jun 21;51(6). pii: 1800921. doi: 10.1183/13993003.00921-2018. Print 2018 Jun. No abstract available.

PMID:
29929960
18.

Mortality in interstitial lung disease: do race and skin colour matter?

Morisset J, Mageto Y, Raghu G.

Eur Respir J. 2018 Jun 14;51(6). pii: 1800892. doi: 10.1183/13993003.00892-2018. Print 2018 Jun. No abstract available.

PMID:
29903831
19.

A non-invasive nanoparticle mediated delivery of triamcinolone acetonide ameliorates diabetic retinopathy in rats.

Mahaling B, Srinivasarao DA, Raghu G, Kasam RK, Bhanuprakash Reddy G, Katti DS.

Nanoscale. 2018 Sep 13;10(35):16485-16498. doi: 10.1039/c8nr00058a.

PMID:
29897081
20.

Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.

Raghu G, van den Blink B, Hamblin MJ, Brown AW, Golden JA, Ho LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Santin-Janin H, Mulder GJ, Bartholmai B, Gupta R, Richeldi L.

JAMA. 2018 Jun 12;319(22):2299-2307. doi: 10.1001/jama.2018.6129.

PMID:
29800034
21.

Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in the USA.

Noth I, Oelberg D, Kaul M, Conoscenti CS, Raghu G.

Eur Respir J. 2018 Jul 27;52(1). pii: 1702106. doi: 10.1183/13993003.02106-2017. Print 2018 Jul. No abstract available.

PMID:
29794129
22.

Identification of usual interstitial pneumonia pattern using RNA-Seq and machine learning: challenges and solutions.

Choi Y, Liu TT, Pankratz DG, Colby TV, Barth NM, Lynch DA, Walsh PS, Raghu G, Kennedy GC, Huang J.

BMC Genomics. 2018 May 9;19(Suppl 2):101. doi: 10.1186/s12864-018-4467-6.

23.

Lung transplantation in idiopathic pulmonary fibrosis.

Kumar A, Kapnadak SG, Girgis RE, Raghu G.

Expert Rev Respir Med. 2018 May;12(5):375-385. doi: 10.1080/17476348.2018.1462704. Epub 2018 Apr 20.

PMID:
29621919
24.

Treatment of Sarcoidosis.

Raghu G, Berman JS, Govender P.

Am J Respir Crit Care Med. 2018 Mar 15;197(6):P9-P10. doi: 10.1164/rccm.1976P9. No abstract available.

PMID:
29543101
25.

Reply to Fernández Pérez: Diagnostic Decision-Making in Hypersensitivity Pneumonitis: Toward a Consensus Statement.

Vasakova M, Morell F, Raghu G.

Am J Respir Crit Care Med. 2018 Jun 15;197(12):1648. doi: 10.1164/rccm.201802-0314LE. No abstract available.

PMID:
29505280
26.

Progress in the management of IPF-related acute exacerbations: a goal for patients, respirologists and intensivists.

Raghu G.

Eur Respir J. 2018 Feb 21;51(2). pii: 1800113. doi: 10.1183/13993003.00113-2018. Print 2018 Feb. No abstract available.

PMID:
29467210
27.

Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?

Wolters PJ, Blackwell TS, Eickelberg O, Loyd JE, Kaminski N, Jenkins G, Maher TM, Molina-Molina M, Noble PW, Raghu G, Richeldi L, Schwarz MI, Selman M, Wuyts WA, Schwartz DA.

Lancet Respir Med. 2018 Feb;6(2):154-160. doi: 10.1016/S2213-2600(18)30007-9. Review.

28.

Air pollution and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA) air-lung study.

Sack C, Vedal S, Sheppard L, Raghu G, Barr RG, Podolanczuk A, Doney B, Hoffman EA, Gassett A, Hinckley-Stukovsky K, Williams K, Kawut S, Lederer DJ, Kaufman JD.

Eur Respir J. 2017 Dec 7;50(6). pii: 1700559. doi: 10.1183/13993003.00559-2017. Print 2017 Dec.

PMID:
29217611
29.

A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis.

Rosas IO, Goldberg HJ, Collard HR, El-Chemaly S, Flaherty K, Hunninghake GM, Lasky JA, Lederer DJ, Machado R, Martinez FJ, Maurer R, Teller D, Noth I, Peters E, Raghu G, Garcia JGN, Choi AMK.

Chest. 2018 Jan;153(1):94-104. doi: 10.1016/j.chest.2017.09.052. Epub 2017 Oct 31.

PMID:
29100885
30.

Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years.

Raghu G.

Eur Respir J. 2017 Oct 26;50(4). pii: 1701209. doi: 10.1183/13993003.01209-2017. Print 2017 Oct. Review.

PMID:
29074545
31.

Reply: Improving Care for Patients with Interstitial Lung Disease, Using Machine Learning, Requires Transparency and Reproducibility.

Kennedy GC, Barth NM, Walsh PS, Huang J, Pankratz DG, Choi Y, Fedorowicz GM, Anderson JD, Raghu G, Martinez FJ, Colby TV, Lynch DA, Brown KK, Groshong SD, Myers JL, Flaherty KR, Steele MP.

Ann Am Thorac Soc. 2017 Dec;14(12):1864-1865. doi: 10.1513/AnnalsATS.201708-654LE. No abstract available.

PMID:
29058451
32.

Idiopathic pulmonary fibrosis.

Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, Swigris JJ, Taniguchi H, Wells AU.

Nat Rev Dis Primers. 2017 Oct 20;3:17074. doi: 10.1038/nrdp.2017.74. Review.

PMID:
29052582
33.

Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential.

Raghu G.

Eur Respir Rev. 2017 Sep 27;26(145). pii: 170071. doi: 10.1183/16000617.0071-2017. Print 2017 Sep 30. Review.

34.

Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study.

Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown K, Calandriello L, Corte TJ, Cottin V, Crestani B, Flaherty K, Glaspole I, Grutters J, Inoue Y, Kokosi M, Kondoh Y, Kouranos V, Kreuter M, Johannson K, Judge E, Ley B, Margaritopoulos G, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Ryerson CJ, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts W, Hansell D, Wells A; IPF Project Consortium.

Eur Respir J. 2017 Aug 31;50(2). pii: 1700936. doi: 10.1183/13993003.00936-2017. Print 2017 Aug.

PMID:
28860269
35.

Occupational Exposures and Subclinical Interstitial Lung Disease. The MESA (Multi-Ethnic Study of Atherosclerosis) Air and Lung Studies.

Sack CS, Doney BC, Podolanczuk AJ, Hooper LG, Seixas NS, Hoffman EA, Kawut SM, Vedal S, Raghu G, Barr RG, Lederer DJ, Kaufman JD.

Am J Respir Crit Care Med. 2017 Oct 15;196(8):1031-1039. doi: 10.1164/rccm.201612-2431OC.

36.

Attenuation of diabetic retinopathy in rats by ellagic acid through inhibition of AGE formation.

Raghu G, Akileshwari C, Reddy VS, Reddy GB.

J Food Sci Technol. 2017 Jul;54(8):2411-2421. doi: 10.1007/s13197-017-2683-8. Epub 2017 May 29.

37.

Current approaches to the management of idiopathic pulmonary fibrosis.

Raghu G, Richeldi L.

Respir Med. 2017 Aug;129:24-30. doi: 10.1016/j.rmed.2017.05.017. Epub 2017 May 30. Review.

PMID:
28732832
38.

Usual Interstitial Pneumonia Can Be Detected in Transbronchial Biopsies Using Machine Learning.

Pankratz DG, Choi Y, Imtiaz U, Fedorowicz GM, Anderson JD, Colby TV, Myers JL, Lynch DA, Brown KK, Flaherty KR, Steele MP, Groshong SD, Raghu G, Barth NM, Walsh PS, Huang J, Kennedy GC, Martinez FJ.

Ann Am Thorac Soc. 2017 Nov;14(11):1646-1654. doi: 10.1513/AnnalsATS.201612-947OC.

PMID:
28640655
39.

Obstructive Sleep Apnea and Subclinical Interstitial Lung Disease in the Multi-Ethnic Study of Atherosclerosis (MESA).

Kim JS, Podolanczuk AJ, Borker P, Kawut SM, Raghu G, Kaufman JD, Stukovsky KDH, Hoffman EA, Barr RG, Gottlieb DJ, Redline SS, Lederer DJ.

Ann Am Thorac Soc. 2017 Dec;14(12):1786-1795. doi: 10.1513/AnnalsATS.201701-091OC.

PMID:
28613935
40.

High-Attenuation Areas on Chest Computed Tomography and Clinical Respiratory Outcomes in Community-Dwelling Adults.

Podolanczuk AJ, Oelsner EC, Barr RG, Bernstein EJ, Hoffman EA, Easthausen IJ, Stukovsky KH, RoyChoudhury A, Michos ED, Raghu G, Kawut SM, Lederer DJ.

Am J Respir Crit Care Med. 2017 Dec 1;196(11):1434-1442. doi: 10.1164/rccm.201703-0555OC.

PMID:
28613921
41.

Hypersensitivity Pneumonitis: Perspectives in Diagnosis and Management.

Vasakova M, Morell F, Walsh S, Leslie K, Raghu G.

Am J Respir Crit Care Med. 2017 Sep 15;196(6):680-689. doi: 10.1164/rccm.201611-2201PP. No abstract available.

PMID:
28598197
42.

Citrus maxima (Pomelo) juice mediated eco-friendly synthesis of ZnO nanoparticles: Applications to photocatalytic, electrochemical sensor and antibacterial activities.

Pavithra NS, Lingaraju K, Raghu GK, Nagaraju G.

Spectrochim Acta A Mol Biomol Spectrosc. 2017 Oct 5;185:11-19. doi: 10.1016/j.saa.2017.05.032. Epub 2017 May 16.

PMID:
28528217
43.

Antacid use and subclinical interstitial lung disease: the MESA study.

Restivo MD, Podolanczuk A, Kawut SM, Raghu G, Leary P, Barr RG, Lederer DJ.

Eur Respir J. 2017 May 19;49(5). pii: 1602566. doi: 10.1183/13993003.02566-2016. Print 2017 May. No abstract available.

44.

Genome-wide association study of subclinical interstitial lung disease in MESA.

Manichaikul A, Wang XQ, Sun L, Dupuis J, Borczuk AC, Nguyen JN, Raghu G, Hoffman EA, Onengut-Gumuscu S, Farber EA, Kaufman JD, Rabinowitz D, Stukovsky KDH, Kawut SM, Hunninghake GM, Washko GR, O'Connor GT, Rich SS, Barr RG, Lederer DJ.

Respir Res. 2017 May 18;18(1):97. doi: 10.1186/s12931-017-0581-2.

45.

Pleuroparenchymal fibroelastosis associated with telomerase reverse transcriptase mutations.

Newton CA, Batra K, Torrealba J, Meyer K, Raghu G, Garcia CK.

Eur Respir J. 2017 May 11;49(5). pii: 1700696. doi: 10.1183/13993003.00696-2017. Print 2017 May. No abstract available.

46.

A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective.

Ryerson CJ, Corte TJ, Lee JS, Richeldi L, Walsh SLF, Myers JL, Behr J, Cottin V, Danoff SK, Flaherty KR, Lederer DJ, Lynch DA, Martinez FJ, Raghu G, Travis WD, Udwadia Z, Wells AU, Collard HR.

Am J Respir Crit Care Med. 2017 Nov 15;196(10):1249-1254. doi: 10.1164/rccm.201702-0400PP. No abstract available.

47.

Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging.

Bravo PE, Raghu G, Rosenthal DG, Elman S, Petek BJ, Soine LA, Maki JH, Branch KR, Masri SC, Patton KK, Caldwell JH, Krieger EV.

Int J Cardiol. 2017 Aug 15;241:457-462. doi: 10.1016/j.ijcard.2017.03.033. Epub 2017 Mar 10.

48.

Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.

Collins BF, Spiekerman CF, Shaw MA, Ho LA, Hayes J, Spada CA, Stamato CM, Raghu G.

Chest. 2017 Jul;152(1):103-112. doi: 10.1016/j.chest.2017.03.004. Epub 2017 Mar 12.

49.

Reply: "The ILD-India Registry: Ignoratio Elenchi" and "The ILD-India Registry: Look Before You Leap".

Singh S, Collins BF, Singh V, Raghu G.

Am J Respir Crit Care Med. 2017 Mar 15;195(6):837-839. doi: 10.1164/rccm.201612-2482LE. No abstract available.

PMID:
28294647
50.

Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis.

Manichaikul A, Sun L, Borczuk AC, Onengut-Gumuscu S, Farber EA, Mathai SK, Zhang W, Raghu G, Kaufman JD, Hinckley-Stukovsky KD, Kawut SM, Jelic S, Liu W, Fingerlin TE, Schwartz DA, Sell JL, Rich SS, Barr RG, Lederer DJ.

Ann Am Thorac Soc. 2017 May;14(5):628-635. doi: 10.1513/AnnalsATS.201606-485OC.

Supplemental Content

Support Center